Discovery of New Uncompetitive Inhibitors of Gluco... - BV FAPESP
Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Discovery of New Uncompetitive Inhibitors of Glucose-6-Phosphate Dehydrogenase

Full text
Author(s):
Mercaldi, Gustavo F. [1, 2] ; Ranzani, Americo T. [1, 2] ; Cordeiro, Artur T. [2]
Total Authors: 3
Affiliation:
[1] Univ Estadual Campinas, Inst Biol, Campinas, SP - Brazil
[2] Brazilian Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, BR-13083970 Campinas, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: JOURNAL OF BIOMOLECULAR SCREENING; v. 19, n. 10, p. 1362-1371, DEC 2014.
Web of Science Citations: 11
Abstract

The enzyme glucose-6-phosphate dehydrogenase (G6PDH) catalyzes the first step of the oxidative branch of the pentose phosphate pathway, which provides cells with NADPH, an essential cofactor for many biosynthetic pathways and antioxidizing enzymes. In Trypanosoma cruzi, the G6PDH has being pursued as a relevant target for the development of new drugs against Chagas disease. At present, the best characterized inhibitors of T. cruzi G6PDH are steroidal halogenated compounds derivatives from the mammalian hormone precursor dehydroepiandrosterone, which indeed are also good inhibitors of the human homologue enzyme. The lack of target selectivity might result in hemolytic side effects due to partial inhibition of human G6PDH in red blood cells. Moreover, the treatment of Chagas patients with steroidal drugs might also cause undesired androgenic side effects. Aiming to identify of new chemical classes of T. cruzi G6PDH inhibitors, we performed a target-based high-throughput screen campaign against a commercial library of diverse compounds. Novel TcG6PDH inhibitors were identified among thienopyrimidine and quinazolinone derivatives. Preliminary structure activity relationships for the identified hits are presented, including structural features that contribute for selectivity toward the parasite enzyme. Our results indicate that quinazolinones are promising hits that should be considered for further optimization. (AU)

FAPESP's process: 13/03983-5 - Functional and structural studies of the enzymes related to the NADPH production in trypanosomatids
Grantee:Artur Torres Cordeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 10/17849-0 - Development of a High Throughput Screening of inhibitors for the enzyme glucose-6-phosphate dehydrogenase from Trypanosoma cruzi
Grantee:Gustavo Fernando Mercaldi
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 12/23682-7 - Structural characterization of malic enzyme of Trypanosoma cruzi and inhibitor discovery by a High-Throughput Screening assay.
Grantee:Américo Tavares Ranzani
Support Opportunities: Scholarships in Brazil - Doctorate